Showing results (151-160 of 189) with videos related to
Sort By:
Pageof 19
American Journal of Physiology. Endocrinology and Metabolism|January 28, 2016
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activityRainey E Patterson, Srilaxmi Kalavalapalli, Caroline M Williams, et al.Journal of Hepatology|January 17, 2025
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLDDiana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.The Journal of Clinical Endocrinology and Metabolism|January 25, 2007
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patientsBogdan Balas, Muhammad R Baig, Catherine Watson, et al.Cell Reports. Medicine|September 6, 2024
Detecting altered hepatic lipid oxidation by MRI in an animal model of MASLDMarc McLeod, Mario C Chang, Anna Rushin, et al.Nature Reviews. Gastroenterology & Hepatology|June 26, 2021
Defining comprehensive models of care for NAFLDJeffrey V Lazarus, Quentin M Anstee, Hannes Hagström, et al.Frontiers in Endocrinology|January 22, 2026
Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohortJosep León-Mengíbar, María M Malagón, Marcelino Bermúdez-López, et al.Frontiers in Endocrinology|January 30, 2023
Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based studyMaría Teresa Julián, Sílvia Ballesta, Guillem Pera, et al.Journal of Hepatology|October 25, 2023
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directionsVlad Ratziu, Marcus Hompesch, Mathieu Petitjean, et al.The New England Journal of Medicine|December 1, 2006
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitisRenata Belfort, Stephen A Harrison, Kenneth Brown, et al.Proceedings of the National Academy of Sciences of the United States of America|July 2, 2003
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1Mary Elizabeth Patti, Atul J Butte, Sarah Crunkhorn, et al.Pageof 19